PALL EBDS
Report
- Report Number
- 1219343-2014-00022
- Event Type
- Injury
- Date Received
- August 4, 2014
- Date of Event
- June 5, 2014
- Report Date
- June 23, 2014
- Manufacturer
- HAEMONETICS CORP.
- Product Code
- MZC
- PMA / PMN Number
- BK070063
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- OH, US
- Reporter Occupation
- NOT APPLICABLE
Narratives
THE PLATELET UNIT COLLECTED ON 06/03/2014 AT THE REPORTING FACILITY WAS SAMPLED AND STORED APPROPRIATELY ACCORDING TO THE FACILITY PROTOCOLS. THE UNIT PASSED BACTERIAL TESTING USING THE EBDS. THE PLATELET UNIT WAS TESTED AT THE HOSPITAL AFTER THE TRANSFUSION REACTION AND WAS POSITIVE FOR STAPHYLOCOCCUS EPIDERMIDIS AND STAPHYLOCOCCUS HOMINIS. THE EBDS DOES NOT DETECT STAPHYLOCOCCUS HOMINIS. THE DEVICE IS NOT BEING RETURNED. THE PLATELET SAMPLE WAS RETURNED TO THE MANUFACTURING SITE. RESULTS ARE NOT AVAILABLE AT THE TIME OF THIS REPORT. A SUPPLEMENTAL REPORT WILL BE FILED WHEN THE RESULTS BECOME AVAILABLE. (B)(4).
HAEMONETICS RECEIVED A COMPLAINT THAT THE PALL ENHANCED BACTERIAL DETECTION SYSTEM (PALL EBDS) RETURNED A FALSE NEGATIVE RESULT WHICH RESULTED IN A TRANSFUSION REACTION. IT WAS REPORTED TO HAEMONETICS THAT A HOSPITAL END-USER TRANSFUSED ONE UNIT OF PLATELETS TO A PATIENT RECEIVING CHEMOTHERAPY FOR ACUTE MYELOID LEUKEMIA. THE COLLECTED PLATELET UNIT HAD BEEN TESTED AT THE COLLECTION SITE FOR BACTERIAL CONTAMINATION USING THE EBDS DEVICE. THE TEST DID NOT DETECT BACTERIAL GROWTH. NO TESTING WAS DONE AT THE HOSPITAL PRIOR TO TRANSFUSION. THE TRANSFUSION RESULTED IN A REACTION WITH A RASH, PRURITUS, FLUSHING CHILLS AND NAUSEA. THE TRANSFUSION WAS TERMINATED AS SOON AS THE REACTION WAS EVIDENT. THE PATIENT RECEIVED BENADRYL AND ATIVAN. THE SYMPTOMS SUBSIDED WITH THE ADMINISTRATION OF THE MEDICATION.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 455249 | PALL EBDS | MZC | HAEMONETICS CORP. |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Hospitalization |